STOCK TITAN
  1. Home
  2. KPHMW

Kiora Pharma (KPHMW) Stock Price, News & Analysis

KPHMW OTC Link

Company Description

For FY2025, Kiora Pharma reported revenue of $0 with net income of -$11K and diluted earnings per share of -$2.64.

This page collects what Stock Titan holds for KPHMW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

KPHMW Rankings

Revenue
$0.0
#3,512
Piotroski F-Score
1/9
#7,290

Latest News

View All

No recent news available for KPHMW.

SEC Filings

View All

[8-K] Kiora (NASDAQ: KPRX) partners with CKD on KIO-301 for retinitis pigmentosa

[SCHEDULE 13G/A] ADAR1 group discloses 9.9% Kiora Pharmaceuticals (KPRX) stake via shares and warrants

[SCHEDULE 13G/A] Nantahala Capital discloses 9.99% Kiora Pharmaceuticals (KPRX) stake via 13G/A filing

[8-K] Kiora Pharmaceuticals (NASDAQ: KPRX) details Q2 loss and $24M financing

[10-Q] Kiora Pharmaceuticals (NASDAQ: KPRX) details Q2 2026 loss and cash runway

Kiora Pharma has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form SCHEDULE 13G/A, 1 Form 10-Q. The most recent filing was submitted on August 19, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KPHMW SEC filings →

Financial Highlights

View Full Financials

operating income reached -$12.8M, and net income was -$11K. Diluted earnings per share stood at -$2.64. The company generated -$10.0M in operating cash flow. With a current ratio of 5.99, the balance sheet reflects a strong liquidity position.

$0
Revenue (FY2025)
-$11K
Net Income (FY2025)
-$2.64
Diluted EPS (FY2025)
-$10.0M
Operating Cash Flow
5.99
Current Ratio
-$12.8M
Operating Income

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the revenue of Kiora Pharma (KPHMW) stock?

The FY2025 revenue of Kiora Pharma (KPHMW) is $0, from its most recent completed fiscal year.

What is the net income of Kiora Pharma (KPHMW)?

The FY2025 net income of Kiora Pharma (KPHMW) is -$11K, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Kiora Pharma (KPHMW)?

The diluted earnings per share (EPS) of Kiora Pharma (KPHMW) is -$2.64 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Kiora Pharma (KPHMW)?

The operating cash flow of Kiora Pharma (KPHMW) is -$10.0M. Learn about cash flow.

What is the current ratio of Kiora Pharma (KPHMW)?

The current ratio of Kiora Pharma (KPHMW) is 5.99, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Kiora Pharma (KPHMW)?

The operating income of Kiora Pharma (KPHMW) is -$12.8M. Learn about operating income.